Merck & Company Inc (MRK HM) stock market data APIs
€122.1996
-1.55(-1.3%)
as of March 4, 2026
Try our APIs with
free plan!
Merck & Company Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MRK.HM.
Prev. Close
122.1996
Open
120.65
High
123.3924
Low
119.6806
52 wk Range
104.2-138.5814
Market Cap
97 608 M
Dividends (Yield)
0.0135
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Merck & Company Inc data using free add-ons & libraries
Get Merck & Company Inc Fundamental Data
Merck & Company Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: 1.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Merck & Company Inc News
New
Health Care Roundup: Market Talk
Find insight on Merck KGaA, Bayer and more in the latest Market Talks covering the health care sector. Continue Reading
Merck KGaA (MKKGY) Lags Q4 Earnings Estimates
Merck KGaA (MKKGY) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.54 per share a year ago. These figures ...
Swarm Oncology appoints Bernhard Ehmer as Chairman
Swarm Oncology Ldd Company announces manufacturing readiness and financing extension ahead of first-in-human clinical study London, United Kingdom, March 5, 2026, Swarm Oncology Ltd. (“Swarm Oncol...
Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings
The company anticipates currency headwinds would continue to weigh on its earnings this year, as the life-sciences and chemical company prepares for a leadership change. Continue Reading
Get Merck & Company Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
